FDA
approval
· 2020-06-02
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
Summary
FDA approved a supplemental application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension, manufactured by Solco Healt…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)